AI-generated summary
The authors report a prospective clinical trial of 23 subjects with vascular and/or pigmented lesions treated with a 532-nm and 1,064-nm laser with cryogen spray cooling. Blinded physician reviewers judged before and after photographs, and the authors report improvement in most cases with no serious adverse events, though the abstract does not describe a control group.
- Participants
- 23
- Who or what was studied
- Adults with vascular and/or pigmented lesions, mean age 53.1 years, 91.3% women, Fitzpatrick skin types II-IV
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The abstract describes a small single-arm trial with no control group and reports results from a short follow-up period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm, 064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.